课题基金 / 基金详情

VALIDITY OF THE AFFECTED DISCORDANT-SIB-PAIR DESIGN

VALIDITY OF THE AFFECTED DISCORDANT-SIB-PAIR DESIGN
受影响的不一致同胞对设计的有效性
批准号:
7600996
负责人:
CHENGGUO XING
金额:
$0.1万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-01 至 2008-07-31

项目摘要

项目成果

CHENGGUO XING的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Genomewide linkage studies are tending toward the use of single-nucleotide polymorphisms (SNPs) as the markers of choice. However, linkage disequilibrium (LD) between tightly linked SNPs violates the fundamental assumption of linkage equilibrium (LE) between markers that underlies most multipoint calculation algorithms currently available, and this leads to inflated afected-relative-pair allele-sharing statistics when founders' multilocus genotypes are unknown. We investigated the impact that the degree of LD, marker allele frequency, and association type, have on estimating the probabilities of sharing alleles identical by descent in multipoint calculations and hence on type I error rates of different sib-pair linkage approaches that assume LE. We showed that marker-marker LD does not inflate type I error rates of affected sib pair ASP) statistics in the whole parameter space, and that, in any case, discordant sib pairs (DSP) can be used to control for marker-marker LD in ASPs. Thus, we advocate the ASP/DSP design with appropriate statistics that test the difference in allele sharing between ASPs and DSPs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
  • 批准号:
    10512091
  • 项目类别:
  • 资助金额:
    $7.63万
  • 财政年份:
    2022
  • 负责人:
    CHENGGUO XING
  • 依托单位:
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
  • 批准号:
    10683294
  • 项目类别:
  • 资助金额:
    $7.63万
  • 财政年份:
    2022
  • 负责人:
    CHENGGUO XING
  • 依托单位:
Dihydromethysticin (DHM) for Lung Cancer Chemoprevention
  • 批准号:
    9271168
  • 项目类别:
  • 资助金额:
    $31.66万
  • 财政年份:
    2016
  • 负责人:
    CHENGGUO XING
  • 依托单位:
Dihydromethysticin (DHM) for Lung Cancer Chemoprevention
  • 批准号:
    9070717
  • 项目类别:
  • 资助金额:
    $24.9万
  • 财政年份:
    2015
  • 负责人:
    CHENGGUO XING
  • 依托单位:
海外基金